Michael H Weisman Selected Research

Michael H Weisman Research Topics

Disease

35	Rheumatoid Arthritis 01/2022 - 09/2002
21	Ankylosing Spondylitis 01/2022 - 05/2007
21	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2004
14	Arthritis (Polyarthritis) 01/2021 - 02/2004
8	Inflammation (Inflammations) 01/2018 - 01/2009
7	Back Pain (Backache) 10/2021 - 08/2012
5	Infections 07/2020 - 09/2002
5	Pain (Aches) 01/2018 - 02/2006
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2012
3	Axial Spondyloarthritis 10/2021 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 01/2014
3	Disease Susceptibility (Diathesis) 01/2019 - 02/2010
3	Psoriatic Arthritis 09/2015 - 04/2005
3	Spondylarthropathies 04/2013 - 05/2007
3	Labyrinth Diseases 06/2009 - 10/2003
2	Genetic Risk Score 01/2022 - 01/2016
2	Hypertension (High Blood Pressure) 01/2022 - 09/2020
2	Osteoarthritis 12/2019 - 02/2006
2	Bronchiectasis 10/2019 - 06/2012
2	Crohn Disease (Crohn's Disease) 01/2019 - 01/2009
2	Spondylitis 01/2019 - 06/2013
2	Neoplasms (Cancer) 01/2019 - 05/2016
2	Necrosis 01/2018 - 12/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2015 - 04/2005
2	Familial Mediterranean Fever (Periodic Disease) 01/2014 - 10/2012
2	Atherosclerosis 01/2014 - 04/2004
2	Lupus Nephritis 08/2012 - 11/2005
2	Joint Diseases (Joint Disease) 12/2009 - 01/2006
1	COVID-19 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 10/2020
1	Uveitis 09/2020
1	Osteoporosis 09/2020
1	Lymphoma (Lymphomas) 07/2020
1	Microscopic Polyangiitis 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2019
1	Anterior Uveitis 01/2019
1	Hypersensitivity (Allergy) 01/2019

Drug/Important Bio-Agent (IBA)

18	AutoantibodiesIBA 01/2022 - 05/2007
9	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2021 - 07/2011
9	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 06/2012
9	Methotrexate (Mexate)FDA LinkGeneric 09/2015 - 11/2002
7	AntibodiesIBA 12/2019 - 12/2005
6	ametantrone (HAQ)IBA 02/2017 - 02/2004
5	cyclic citrullinated peptideIBA 04/2021 - 09/2013
5	Biological ProductsIBA 09/2020 - 12/2007
5	Monoclonal AntibodiesIBA 05/2016 - 01/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 09/2002
4	Rheumatoid FactorIBA 01/2021 - 06/2012
4	Peptides (Polypeptides)IBA 12/2019 - 07/2011
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2013
4	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 05/2015 - 08/2012
4	Biomarkers (Surrogate Marker)IBA 01/2014 - 08/2004
4	Adalimumab (Humira)FDA Link 02/2010 - 01/2003
3	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2009
3	Vitamin D FDA LinkGeneric 01/2022 - 05/2009
3	hydroxide ionIBA 01/2022 - 05/2009
3	SteroidsIBA 04/2021 - 06/2009
3	Pharmaceutical PreparationsIBA 09/2020 - 01/2009
3	Immunoglobulin G (IgG)IBA 12/2019 - 12/2005
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 08/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016 - 10/2003
3	CytokinesIBA 06/2013 - 06/2003
3	Infliximab (Remicade)FDA Link 05/2008 - 09/2002
3	Etanercept (Enbrel)FDA Link 07/2007 - 09/2002
2	Opioid Analgesics (Opioids)IBA 09/2020 - 01/2018
2	GlucocorticoidsIBA 01/2020 - 05/2012
2	Rituximab (Mabthera)FDA Link 01/2020 - 12/2007
2	Immunoglobulin A (IgA)IBA 12/2019 - 09/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2016
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019 - 01/2009
2	AntigensIBA 01/2018 - 01/2017
2	C-Reactive ProteinIBA 10/2017 - 10/2013
2	EpitopesIBA 01/2017 - 01/2016
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 02/2016
2	rilonacept FDA Link 01/2014 - 10/2012
2	EnzymesIBA 09/2013 - 02/2006
2	Antimalarials (Antimalarial Agents)IBA 09/2012 - 04/2004
2	Interleukin-1 (Interleukin 1)IBA 02/2010 - 09/2002
2	Prednisone (Sone)FDA LinkGeneric 06/2009 - 11/2002
2	Abatacept (Orencia)FDA Link 12/2007 - 11/2006
2	Antirheumatic Agents (DMARD)IBA 04/2005 - 03/2004
1	25-hydroxyvitamin DIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	LipidsIBA 01/2021
1	SolutionsIBA 10/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	P-2 (P 2)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 12/2019
1	Protein Glutamine gamma Glutamyltransferase 2IBA 04/2019
1	Cardiolipins (Cardiolipin)IBA 04/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019

Therapy/Procedure

18	Therapeutics 07/2020 - 11/2002
2	Biological Therapy 01/2019 - 09/2002
1	Contraception (Birth Control) 08/2020
1	Ambulatory Care (Outpatient Care) 07/2020
1	Remission Induction 01/2020
1	Traction 10/2019